Home|Contact us|Site map
 

Our investors





CIC - Vizille Capital Innovation is the venture capital subsidiary of the CIC - Banque de Vizille Group. Its objective is to invest in promising technology companies in their early stages of development with a high growth potential in dynamic sectors such as information technologies, telecommunications, electronics, life sciences, new materials, and clean technologies. CIC – Vizille Capital Innovation’s policy is aimed at providing assistance over time (5-7 years) to high-tech start-ups, which will ultimately lead them on the right track to succeed. This involvement is achieved by working closely with the company through advices and networking, but without interfering in the day-to-day management of the company. Investment levels are suited to each case – usually between €0.5 and €3 million - and injected gradually in several phases, as development needs rise. CIC - Vizille Capital Innovation usually invests with other financial partners, often as lead or co-lead investor.




CDC Entreprises – a wholly-owned subsidiary of Caisse des Dépôts – manages private equity funds of funds and co-investment funds with the mission of promoting the French private equity industry, mainly for its own account. It supports venture and growth capital, from seed to late stage financing, on a local and national level, in order to facilitate high-tech, fast-growing or traditional SMEs up to € 15 million per company. CDC Entreprises now implements and manages a new investment program called "France Investissement" (2006-2012), which aims to promote tomorrow’s French champions at an international level. A total of € 2 billion have been allocated to be invested by CDC Entreprises in this program.




Avenir Entreprises is a small-cap investor related to Caisse des Dépôts et Consignations. Since its launch in 1984, the company has invested in over 500 French companies in all sectors with success such as Nocibé and Maisons du Monde in the retail industry, Floreane Medical Implants in medical technologies and B&B in the hotel industry. The company consists of a dozen professionals in Paris, Lyon and Nantes.

Copyright © 2007. Oncodesign® Biotechnology. All rights reserved